𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin

✍ Scribed by Kerstin Schultze; Barbara Böck; Anika Eckert; Lena Oevermann; Dirk Ramacher; Otmar Wiestler; Wilfried Roth

Publisher
Springer
Year
2006
Tongue
English
Weight
580 KB
Volume
11
Category
Article
ISSN
1360-8185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quercetin sensitizes human hepatoma cell
Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation
✍ Jin Yeop Kim; Eun Hee Kim; Seok Soon Park; Jun Hee Lim; Taeg Kyu Kwon; Kyeong So 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

## Abstract This study demonstrates that combined treatment with subtoxic doses of quercetin (3′,3′,4′,5,7‐pentahydroxyflavone), a flavonoid found in many fruits and vegetables, plus tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) induces rapid apoptosis in TRAIL‐resistant hepatocel

Inhibition of CDK4 impairs proliferation
Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin
✍ Michaela Retzer-Lidl; Roland M. Schmid; Günter Schneider 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

## Abstract Pancreatic ductal adenocarcinoma is one of the most common causes of cancer death in Western countries with an average survival after diagnosis of 3–6 months and a five‐year survival rate under 5%. Because of the lack of effective therapies, there is the need to characterize new molecul

R-roscovitine sensitizes anaplastic thyr
R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-κB pathway
✍ Michela Festa; Antonello Petrella; Silvia Alfano; Luca Parente 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 386 KB

## Abstract Among thyroid carcinomas, highly aggressive undifferentiated or anaplastic carcinomas still await effective therapeutic strategies. __R__‐roscovitine is a novel cyclin‐dependent kinase inhibitor in clinical trials as anti‐cancer agent. We have investigated the effects of __R__‐roscoviti